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Serotonin Activates Human Monocytes and Prevents
Apoptosis
Fujiko Soga1, Norito Katoh1, Tomoko Inoue1 and Saburo Kishimoto1
Monocytes play a critical role in chronic atopic dermatitis (AD) and are the primary leukocytes that interact with
activated platelets. Although activated platelets release a variety of mediators, the role of platelets in cutaneous
allergic inflammation remains unclear. Serotonin (5-hydroxytryptamine, 5-HT) is one of the prototypic
mediators produced by activated platelets. We examined the effect of 5-HT on the function and lifespan of
human monocytes. Normal human monocytes treated with 5-HT exhibited upregulated expression of
costimulatory molecules, enhanced capacity to produce cytokines following lipopolysaccharide treatment,
and to stimulate allogeneic CD4þ T cells. 5-HT also attenuated the apoptosis in normal human monocytes in a
dose-dependent manner. The plasma levels of 5-HT were increased in patients with AD compared with controls
and correlated with the SCORAD index. 5-HT also inhibited monocyte apoptosis in these patients. 5-HT
upregulated Bcl-2 and Mcl-1, and inhibited the activation of caspase-3. The effects of 5-HT on monocyte
apoptosis were mediated by the 5-HT1 and/or 5-HT7 receptors. 5-HT and a 5-HT1/6/7-receptor agonist induced
phosphorylation of extracellular signal-regulated kinase1/2 and activation of nuclear transcription factor-kB.
These findings support that 5-HT activates monocytes and inhibits apoptosis, allowing them to remain in the
tissue and contribute to chronic inflammation.
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INTRODUCTION
Atopic dermatitis (AD) is a chronically recurring inflammatory
skin disease that is frequently seen in individuals with a
genetic predisposition to produce high levels of IgE following
exposure to food and environmental allergens (Leung and
Bieber, 2003; Leung et al., 2004). However, the mechanism
contributing to the chronicity of this inflammatory skin disease
remains unclear. Monocytes probably play a pivotal role in the
establishment of chronic lesions in AD, as chronic AD is
associated with activation of circulating (Polla et al., 1992)
and infiltrating monocytes (Leung et al., 1992). Although the
lack of appropriate exogenous stimuli can lead to apoptosis of
monocytes (Mangan et al., 1993), under the influence of
activating signals, such as cytokines (Mangan and Wahl, 1991;
Mangan et al., 1991) and allergen stimulation (Katoh et al.,
2000), monocytes can actually exhibit a prolonged life span.
Indeed, monocytes from patients with chronic AD exhibit a
significantly lower rate of apoptosis in vitro compared with
those from normal healthy individuals (Bratton et al., 1995).
Therefore, it has been suggested that enhanced survival of
activated monocytes in inflamed tissues can contribute to the
establishment of chronic inflammation in AD.
In vivo, monocytes are the primary leukocytes that interact
with activated platelets by forming aggregates (Rinder et al.,
1992; Furman et al., 1998). Platelets contain many mediators
and may play a critical role in immunological and
nonimmunological inflammation (Page, 1989). Serotonin
(5-hydroxytryptamine, 5-HT) is an important mediator that
is involved in various physiological and pathological condi-
tions, including immediate hypersensitivity reaction and
inflammation (Matsuda et al., 1997; Ameisen et al., 1998;
Lundeberg et al., 1999). Platelets release 5-HT following
aggregation after hemorrhage or after the engagement of the
high-affinity IgE receptor (FceRI) on their surface by antigens
(Hasegawa et al., 1999). In AD, scratching because of severe
itchiness often results in excoriation and platelet aggregation
at the lesion. Engagement of FceRI on platelets by environ-
mental allergens may also occur in these lesions. Thus,
monocytes in AD lesions could be exposed to 5-HT.
Although 5-HT has been shown to play an important role
in contact hypersensitivity through direct activation of local
vascular capillary endothelial cells and attracting effector T
cells into the tissue (Matsuda et al., 1997; Ameisen et al.,
1998; Lundeberg et al., 1999), it remains unclear whether
5-HT contributes to the chronicity of AD. Moreover, apart from
their effect on cytokine production (Idzko et al., 2004; Du¨rk
et al., 2005), little information has been available regarding the
effect of 5-HT on the function and life span of monocytes.
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In this investigation, we demonstrated that 5-HT activates
monocytes and prevents monocytic apoptosis via 5-HTR1
and/or 5-HTR7 receptors. It is suggested that these effects of
5-HT on monocytes contribute to the establishment of
chronic lesions and may provide new insight into the
pathogenic relationship between these cells and platelets
in AD.
RESULTS
5-HT alters the phenotype and function of monocytes
At the start of culturing, the cells in a typical experiment
consisted of 95% monocytes, as indicated by CD14 expres-
sion and a typical light scattering profile. To examine the
effect of 5-HT on the phenotype of the monocytes, cells were
incubated for 60 minutes in the presence or absence of 10 mM
5-HT, washed, and then cultured for 24 hours in culture
medium supplemented with 10% fetal bovine serum. This
concentration of 5-HT is relevant in physiological or
pathological circumstances because the release of 5-HT
during platelet aggregation may reach local concentrations of
100mM at the immediate site of release (Benedict et al.,
1986). Treatment with 5-HT induced a significant increase in
the expression of costimulatory molecules, such as CD40,
CD80, and CD86, on the surface of monocytes from healthy
non-atopic individuals, whereas no alterations in the expres-
sion of major histocompatibility complex class II molecules
were observed (Figure 1a). We next examined the effects of
5-HTR agonists on the expression of CD86. As shown in
Figure 1b, a 5-HTR1/6/7 agonist induced a significant increase
in the expression of CD86 by monocytes. However, 5-HTR2
and 5-HTR3 agonists did not increase the expression of CD86
significantly. To exclude the possibility that this phenomenon
is caused by nonspecific effects of contaminating lipopoly-
saccharide (LPS) in our system, monocytes were cultured in
culture medium with or without 100mg/ml polymyxin B,
which forms a deactivating complex with LPS (Manna and
Aggarwal, 1999). In the presence of polymyxin B, 10 ng/ml
LPS, which was a much higher concentration than might
occur with contamination (i.e., less than 10 pg/ml), did not
increase the expression of CD86 (Figure 1b). The expression
of CD86 on monocytes treated with 5-HT or its agonists was
not affected regardless of the presence or absence of
polymixn B (Figure 1b); thus refuting the possible effect of
contaminating LPS.
Monocytes/macrophages contribute to adaptive immune
responses by acting as antigen-presenting cells. Therefore, we
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Figure 1. Effect of 5-HT on the phenotypes and function of monocytes. (a) Monocytes (1 106 cells/ml in12-well plates) were incubated with (thick line) or
without (thin line) 10mM 5-HT for 60 minutes, washed three times and then cultured for 24 hours in 10% fetal bovine serum-supplemented culture medium. The
expression of surface markers was determined by flow cytometric analysis. The overlay histograms represent the data from 10 independent experiments
using monocytes from different donors. The gray histograms correspond to the isotype control. (b) Monocytes (1 106 cells/ml in 12-well plates) were incubated
with or without 10 mM 5-HT, 10 mM 5-HTR agonist, or 10 ng/ml LPS for 60 minutes, washed, and then cultured for 24 hours in 10% fetal bovine
serum-supplemented culture medium with (open square) or without (closed square) polymyxin B. The expression of CD86 was determined by flow cytometric
analysis. Data are presented as the mean7SEM of 10 independent experiments using monocytes from different donors. (c) Monocytes were incubated with
10mM of 5-HT (open circle), 10 ng/ml LPS in the presence (open triangle) or absence of (closed triangle) polymyxin B, or without 5-HT (open square) for
60 minutes, washed three times, and then cocultured with purified responder allogeneic CD4þ T cells for 4 days in 10% fetal bovine serum-supplemented
culture medium. Uptake of [3H]thymidine was assessed. Data are presented as the mean7SD of eight independent experiments in triplicate. (d) Monocytes
(1106 cells/ml in 12-well plates) were incubated with or without 10mM 5-HT for 60 minutes, washed, and then cultured for 24 hours in 10% fetal bovine
serum-supplemented culture medium without polymyxin B. The cells were then stimulated with 10 ng/ml LPS for 60 minutes and cultured for an additional
24 hours. The cytokine concentrations of the cell culture supernatants (1 106 cells/ml) were measured by ELISA. The data are presented as the mean7SEM
of six independent experiments. *Po0.05 compared with untreated cells.
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examined whether 5-HT affects the capacity to stimulate T
cells in the allogeneic mixed lymphocyte reaction. As shown
in Figure 1c, monocytes treated with 5-HT exhibited
significantly increased stimulatory activity toward allogeneic
CD4þ T cells compared with controls, suggesting that
5-HT potentiates their antigen-presenting capacity. Although
the production of pro- and anti-inflammatory cytokines
by monocytes/macrophages is essential for inflammatory
responses, little information is available about the effect of
5-HT on cytokine-producing capacity by monocytes. There-
fore, we examined whether 5-HT affected the stimulated
or unstimulated production of cytokines by monocytes. As
shown in Figure 1d, 5-HT did not induce spontaneous
cytokine production in monocytes after 24 hours of treatment
when it was added at the beginning of culture. On the other
hand, 5-HT significantly enhanced the production of tumor
necrosis factor (TNF)-a and IL-6 after stimulation with LPS
without polymyxin B.
5-HT prevents apoptosis induced by serum removal and
Fas/Fas ligand ligation
Human monocytes cultured in the absence of appropriate
exogenous stimuli undergo apoptosis, whereas the onset of
apoptosis can be prevented by activating signals, such as
cytokines, that cause them to differentiate into macrophages
or dendritic cells (DCs). These results raise the possibility that
5-HT-mediated signals prolong the survival of monocytes,
thereby contributing to the establishment of chronic allergic
inflammation. In an initial experiment to induce apoptosis,
monocytes from healthy nonatopic individuals were cultured
for various time periods without serum and the proportion of
apoptotic cells was assessed by flow cytometry using annexin
V- and propidium iodide-staining. Immediately after isola-
tion, apoptotic cells were hardly detectable (data not shown),
whereas about 45% of monocytes underwent apoptosis after
24 hours without serum (Figure 2a). In contrast, pretreatment
with 5-HT reduced spontaneous apoptosis by serum depriva-
tion (Figure 2a and b). This rescue effect occurred in a dose-
dependent manner and was highest at 100mM (Figure 2a).
A concentration of 10mM 5-HT was used in subsequent
experiments. To exclude the possibility that contaminating
LPS in our system caused the rescue effect from apoptosis,
monocytes were cultured in culture medium with or without
100mg/ml polymyxin B. Treatment with 10 ng/ml of LPS in
culture medium containing polymyxin B did not inhibit the
spontaneous apoptosis (Figure 2c), suggesting that the effect
observed herein was not because of LPS contamination. A
significant decrease in subdiploid DNA was also observed in
the 5-HT-treated monocytes (Figure 2d). Monocytes were
cultured with 5-HT for varying time periods and the
inhibitory effect was significant up to 48 hours (Figure 2e).
To examine whether 5-HT induced endogenously produced
cytokines might affect the lifespan of monocyte, culture
supernatant from monocytes pretreated with 5-HT for
60 minutes were harvested after 24 hours and cells were
cultured in the supernatant. The culture supernatant of
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Figure 2. 5-HT prevents monocyte apoptosis. Monocytes (2 106 cells/ml in 12 75 mm polypropylene tubes) were incubated in the presence of different
concentrations of 5-HT (100 nM to 100mM) or 10 ng/ml LPS with (open square) or without (closed square) polymyxin B for 60 minutes, washed three times, and
then cultured for (a–d) 24 and (e) 72 hours in culture medium without serum. The proportion of apoptotic cells was assessed by flow cytometry for (a–c) annexin
V- and propidium iodide or (d) for subdiploid DNA content with propidium iodide staining. (e) Time course of monocyte apoptosis induced by serum
deprivation, (f) expression of CD95/Fas on monocytes after 5-HT treatment, and (g) the effect of 5-HT on apoptosis induced by anti-CD95/Fas mAb CH11
(0.1 mg/ml). (a and c) The data are presented as the mean7SEM of 10 experiments with monocytes from different donors. (e–g) The data are presented as the
mean7SEM of eight experiments with monocytes from different donors. (b and d) Each histogram and dot plot represents the results of one of 10 separate
experiments that produced similar results. *Po0.05 compared with untreated cells.
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monocytes pretreated with 5-HT did not exhibit any
significant antiapoptotic effect, suggesting that the observed
phenomenon is due to a direct effect of 5-HT (annexin
V-positive cells; 38.573.31 vs 37.875.49%; nil vs 5-HT;
n¼7, P¼0.643).
In a second approach, we examined whether 5-HT
affected anti-CD95/Fas-induced apoptosis. CD95/Fas expres-
sion was not significantly influenced by 5-HT (Figure 2f), thus
excluding the possibility that 5-HT modulates the expression
of CD95/Fas and indirectly affects the rate of Fas/Fas ligand-
induced apoptosis in monocytes. Monocytes were cultured
with anti-CD95/Fas mAb CH11 in the absence or presence of
5-HT for 60 minutes, washed, and then cultured for 24 hours.
Fas/Fas ligand-mediated apoptosis was examined by annexin
V staining. As shown in Figure 2g, 5-HT attenuated the
apoptosis induced by Fas/Fas ligand interaction. These results
suggest that 5-HT is able to induce a protective antiapoptotic
effect in monocytes.
Increased levels of 5-HT in plasma and 5-HT prevents
monocytic apoptosis in AD patients
It was reported that increased levels of free 5-HT were present
in the plasma of symptomatic asthmatic patients and
correlate directly with clinical status and inversely with
pulmonary function (Lechin et al.,1996; Cazzola and Matera,
2000; Barnes, 2001). We therefore examined the levels of
5-HT in plasma from chronic AD patients. As shown in
Figure 3a, plasma levels of 5-HT were significantly higher in
AD patients compared with normal healthy donors and patients
with psoriasis. Plasma levels of 5-HT correlated with the
SCORAD index (Table 1). However, there was no significant
correlation between the 5-HT levels and serum IgE levels,
serum lactate dehydrogenase, or peripheral eosinophil counts
(Table 1). A recent study has suggested that human
monocytes express 5-HT1E, 5-HT2A, 5-HT3, 5-HT4, and
5-HT7 mRNAs (Du¨rk et al., 2005). As shown in Figure 3b,
there was no difference of 5-HTR mRNA expression between
the AD patients and healthy donors by semiquantitative
reverse transcriptase (RT)-PCR. Monocytes from AD patients
significantly exhibited a lower incidence of spontaneous
apoptosis by serum deprivation than monocytes from normal
healthy donors (Figure 3c), which is consistent with previous
report (Bratton et al., 1995). The percentage of monocytes
undergoing spontaneous apoptosis was not significantly
correlated with the plasma levels of 5-HT in patients with
AD (Table 1). We then examined the antiapoptotic effect of
5-HT on monocytes from patients with AD. Pretreatment
of monocytes from AD patients with 5-HT also significantly
reduced spontaneous apoptosis (Figure 3c and d).
5-HT prevents apoptosis in monocytes via the 5-HT1
and/or 5-HT7 receptor
To determine which receptor was responsible for the 5-HT-
induced inhibition of apoptosis, we cultured monocytes in
the presence of different concentrations of 5-HTR agonists
and examined their effects on spontaneous apoptosis by
serum deprivation. As shown in Figure 4a, a 5-HTR1/6/7
agonist prevented apoptosis in a dose-dependent manner,
whereas 5-HTR2 or 5-HTR3 agonists did not exhibit any
effect. In addition, we preincubated monocytes with 5-HTR
antagonists before adding 5-HT. The 5-HTR1/6/7 antagonist,
but not 5-HTR2A or 5-HTR3 antagonists blocked the
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Figure 3. Levels of plasma 5-HT are increased in AD patients and 5-HT
prevents apoptosis of monocytes from these patients. (a) Plasma levels of
5-HT in healthy donors (control: n¼11), patients with AD (n¼11), and
patients with plaque psoriasis (n¼ 10). (b–d) Monocytes (2106 cells/ml
in12 75 mm polypropylene tubes) were incubated with 10 mM 5-HT for
60 minutes, washed, and then cultured for 24 hours in the culture medium
supplemented (b) with 10% fetal bovine serum or (c and d) without serum.
(b) Total RNA was then extracted for RT-PCR for 5-HT1E (1E), 5-HT2A (2A),
5-HT3 (3), 5-HT4 (4), and 5-HT7 (7) in monocytes from healthy donors
(control) and patients with AD. (c and d) Alternatively, the proportion of
apoptotic cells was assessed by flow cytometry using annexin V- and
propidium iodide staining. (a and c) The data are presented as the
mean7SEM of 11 independent experiments with monocytes from different
donors. *Po0.05. Results are representative of (b) five or (d) 11 experiments.
Table 1. Correlation between the level of 5-HT in
plasma and other predictors of disease activity in AD
Median value Correlation Analysis
(range) R P
Serum IgE (U/ml) 3909 (551–43900) 0.109 0.7578
Serum LDH (U/l) 246 (166–408) 0.177 0.6128
Eosinophil (counts/ml) 430 (190–1090) 0.403 0.2267
SCORAD index 37 (22–48.5) 0.825 0.0009
% spontaneous apoptosis 24 (17–32) 0.307 0.370
AD, atopic dermatitis; IgE, immunoglobulin E; LDH, lactate dehydrogenase.
Reference values: serum IgE, 0–380 U/ml; serum LDH, 114–243 U/l;
peripheral eosinophil counts, o420/ml, n=11.
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protective effect of 5-HT (Figure 4b). These results suggest
that the 5-HT-induced antiapoptotic effect is mediated by
5-HTR1 and/or 5-HTR7.
Effect of 5-HT on the expression of the Bcl-2 family proteins
and activated caspase-3
The Bcl-2 family of proteins is known to play a role in
regulating apoptosis (Yang and Korsmeyer, 1996; Lagasse and
Weissman, 1997). Therefore, we examined whether expres-
sion of the Bcl-2 family of proteins in monocytes was affected
by 5-HT. Monocytes were incubated with 5-HT, a 5-HTR
agonist, or LPS in the presence or absence of polymyxin B for
60 minutes, washed, and then cultured for 24 hours. Intra-
cellular expression of the Bcl-2 family proteins was analyzed
by flow cytometry. As shown in Figure 5a, 5-HT and a 5-
HTR1/6/7 agonist enhanced the expression of Bcl-2 and Mcl-1
in monocytes compared with controls, whereas 5-HT did not
significantly affect the expression of Bcl-xL. Caspases play a
role in many forms of apoptosis (Green, 1998). Among the
caspases, a central role in the execution of apoptosis has
been demonstrated for caspase-3. Therefore, we examined
whether the expression of active caspase-3 was affected by
5-HT or a 5-HTR agonist. As shown in Figure 5b, the serum
deprivation-induced apoptosis was characterized by signifi-
cant expression of activated caspase-3. Treatment with 5-HT
and a 5-HTR1/6/7 agonist significantly reduced the percentage
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Figure 4. 5-HT prevents monocyte apoptosis via the 5-HTR1 and/or
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culture medium. The data are presented as the mean7SEM of eight
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Figure 5. Effect of 5-HT on Bcl-2 proteins and activated caspase-3
expression in monocytes. Monocytes (2106 cells/ml in 12 75 mm
polypropylene tubes) were incubated with or without 10 mM 5-HT, 10 mM
5-HTR agonist, or 10 ng/ml LPS in the presence or absence of polymyxin B for
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without fetal bovine serum. (a) Expression of Bcl-2 family proteins was
analyzed by flow cytometry. The relative fluorescence intensity (rFI) was
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molecule)–MFI (isotype control)/MFI (isotype control). The data are presented
as the mean rFI7SEM of eight independent experiments. (b) Expression of
activated caspase-3 in monocytes following serum removal and stimulation
with anti-CD95/Fas mAb CH11 (0.1mg/ml). The data are presented as the
mean7SEM of eight experiments with monocytes from different donors.
*Po0.05 compared with untreated cells.
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of monocytes expressing activated caspase-3. When apop-
tosis was induced by Fas/Fas ligand interaction, 5-HT also
blocked caspase-3 activation significantly (Figure 5b).
Stimulation with 5-HT and a 5-HT1/6/7-receptor agonist
induces ERK1/2 phophorylation and NF-jB activation
It has been demonstrated that agonist-induced release of the
G protein bg complex results in the activation of extracellular
signal-regulated kinase (ERK)1/2 enzymes that regulate many
cellular events, including survival, in various cell types
(Adayev et al., 2003). Therefore, we examined whether
stimulation with 5-HT and a 5-HTR agonist activated ERK1/2.
As shown in Figure 6a, stimulation with 5-HT and a
5-HTR1/6/7 agonist, but not 5-HTR2 or 5-HTR3 agonists,
induced ERK1/2 phosphorylation. As a wide range of stimuli
can lead to NF-kB activation of target genes that are involved
in inflammation or cell growth and differentiation, we
examined the effect of 5-HT on NF-kB p65 nuclear
translocation. Monocytes were stimulated with 5-HT or a
5-HTR agonist and the levels of NF-kB p65 were determined
in nuclear extracts. These results demonstrated that free
p65 levels were significantly increased compared with
untreated monocytes following stimulation with 5-HT or a
5-HTR1/6/7 agonist (Figure 6b).
DISCUSSION
5-HT is synthesized and released mainly by blood platelets in
humans in peripheral tissues, although 5-HT is present
in mast cell granules in rodents. Platelet aggregation or the
engagement of FceRI on their surface antigens promotes
the release of 5-HT (Hasegawa et al., 1999). Recently, a wide
variety of immunomodulatory functions of 5-HT have been
demonstrated, including migration, phagocytosis, generation
of superoxide anion, and cytokine production in lympho-
cytes, monocytes, and DC (Young et al., 1993; Iken et al.,
1995; Laberge et al., 1996; Cloez-Tayarani et al., 2003; Idzko
et al., 2004; Du¨rk et al., 2005). It is therefore suggested that
5-HT is involved in the pathological mechanism of allergic
inflammation. In this study, we provide additional evidence
regarding the immunomodulatory effects of 5-HT on mono-
cytes, i.e., (1) 5-HT activates monocytes and upregulates the
expression of costimulatory molecules, potentiates cytokine-
producing capacity following LPS stimulation, and enhances
antigen-presenting capacity in allogeneic mixed lymphocyte
reaction and (2) 5-HT rescues monocytes from apoptosis,
leading to prolongation of their life span. All of these
phenomena could contribute to the amplification and
chronicity of allergic inflammation.
In this study, treatment of monocytes with 5-HT resulted in
increased expression of costimulatory molecules, such as
CD40, CD80, CD86, but not major histocompatibility
complex class II molecules. It has been shown that the
expression of these molecules on monocytes/macrophages is
differentially regulated (Badie et al., 2002; Bracci-Laudiero
et al., 2005), although the precise mechanisms of their
regulation remain unclear. These costimulatory molecules
are essential for efficient antigen presentation and the lack of
signals mediated by these molecules results in anergy (Yi-qun
et al., 1997). In addition, 5-HT increased the capacity of
monocytes to produce IL-6 and TNF-a following LPS-
stimulation. Idzko et al. (2004) reported that treatment of
LPS-primed monocytes with 5-HT resulted in increased
production of IL-6 and reduced production of TNF-a (Du¨rk
et al., 2005), and suggested a role for cyclic adenosine
monophosphate in this biphasic regulatory mechanism. As
monocytes were cultured for 24 hours after initial treatment
with 5-HT and subsequently stimulated with LPS in our study,
a different signaling pathway might be induced in the
regulation of TNF-a production. Above all, the enhanced
expression of costimulatory molecules and production of
proinflammatory cytokines following LPS stimulation in 5-
HT-treated monocytes may correlate with their enhanced
antigen-presenting capacity.
Unstimulated monocytes rapidly undergo physiological
changes resulting in programmed cell death. However,
apoptosis of monocytes can be prevented by various
exogenous stimuli that are related to allergic inflammation,
including LPS, TNF-a, IL-1b, CD40, FceRI ligation, and
another prototypic monoamine, histamine (Mangan et al.,
1991; Kiener et al., 1995; Katoh et al., 2000, Soga et al.,
2007). In addition, the platelet-derived a-chemokine, platelet
factor 4, prolongs monocyte survival (Scheuere et al., 2000).
Indeed consistent with a previous report (Bratton et al., 1995),
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Figure 6. 5-HT induces ERK1/2 phosphorylation and NF-jB activation.
Monocytes were cultured with or without 10mM 5-HT, 5-HTR agonists,
10 ng/ml LPS in the presence or absence of polymyxin B in the 10% fetal
bovine serum-supplemented culture medium. (a) After 30 minutes, levels of
phosphorylated ERK1/2 were determined in cell extracts (1105 cells/100 ml
in 96-well plates). (b) After 40 minutes, the levels of NF-kB p65 in nuclear
extracts (2 106 cells/ml in 12-well plates) were measured, as described in
the Materials and Methods. Data are presented as the mean7SD of data from
six experiments in triplicate. *Po 0.05 compared with untreated cells.
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this study demonstrated that monocytes from patients with
AD exhibited decreased apoptosis, suggesting that monocytes
are stimulated to survive in the circulation of AD patients by
these inflammatory signals. More interestingly, we showed
that 5-HT prevents monocyte apoptosis in normal healthy
donors and patients with AD, providing further evidence that
mediators stored in platelet granules are involved in
monocyte survival during inflammatory processes in vivo.
The percentage of monocytes undergoing spontaneous
apoptosis was not significantly correlated with the plasma
levels of 5-HT in patients with AD, suggesting that survival
signals besides 5-HT such as proinflammatory cytokines in
circulation would also be involved in the prolongation of
their lifespan in these patients. As semiquantitative RT-PCR
did not demonstrate a difference in mRNA expression for
5-HTRs in monocytes between control subjects and
AD patients, we consider that the prolonged lifespan of
monocytes from patients with AD after 5-HT treatment could
be attributed to a simple additive effect of 5-HT in monocytes
primed by some other mediators in the circulation. Alter-
natively, signal transduction pathways such as ERK and
NF-kB in the monocytes of AD patients might be
hyper-responsive because T-cell antigen-receptor-mediated
activation of ERK cascade and NF-kB signaling were
enhanced in T cells in model mice of AD (Tenda et al., 2006).
As monocytes are the precursors of macrophages and DC,
stimuli that can prolong their life span may also induce
differentiation of these cells into macrophages or DC. For
example, stimulation with platelet factor 4 and ligation of
FceRI induces monocyte differentiation into macrophages,
whereas TNF-a treatment skews their differentiation toward
DC (Scheuere et al., 2000; Novak et al., 2001; Chomarat
et al., 2003). We recently demonstrated that histamine,
another prototypic monoamine mediator in allergic inflam-
mation, induces monocyte differentiation into CD1aCD14þ
DC in the presence of IL-4 and granulocyte macrophage
colony stimulation factor (Katoh et al., 2005). Macrophages
exhibit a significant capacity for phagocytosis and the
production of proinflammatory cytokines and low stimulatory
capacity toward resting T cells. In contrast, DCs exhibit low
phagocytic activity but a strong capacity for initiating primary
and secondary T-cell responses as professional antigen-
presenting cells (Novak et al., 2001). The functional
divergence of these cells would contribute to the regulation
and characterization of the inflammatory processes. Interest-
ingly, monocytes cultured in the presence of IL-4, granulo-
cyte macrophage colony stimulation factor, and 5-HT
differentiate into DC with weak antigen-presenting capacity
and reduced expression of costimulatory molecules (Katoh
et al., 2006).
In this study, we demonstrated that 5-HTR1 and/or 5-HTR7
were involved in the protective effect of monocyte survival.
Du¨rk et al. (2005) suggested that 5-HTR7 activation increased
intracellular cyclic adenosine monophosphate and induced
production of cytokines, such as IL-1b and IL-6, in LPS-
primed monocytes. According to their report, a 5-HTR1
agonist did not influence these responses. However, it
remains unclear whether additional signaling pathways are
induced via the 5-HTR1. In this study, we demonstrated that
5-HT induced ERK phosphorylation and NF-kB activation via
stimulation of the 5-HTR1and/or 5-HTR7. Activation of these
signaling pathways may be involved in the antiapoptotic
effect of 5-HT. On the other hand, the culture supernatant of
monocyte pretreated with 5-HT did not show any significant
antiapoptotic effect. In addition, 5-HT did not affect the
production of cytokines by unstimulated monocytes. Taken
together, it is suggested that the antiapoptotic effect observed
in this study was not because of endogenously produced
cytokines but a direct effect of 5-HT.
The increased plasma levels of platelet-derived chemo-
kines, such as b-thromboglobulin and platelet factor 4, in
patients with AD suggest that platelets are activated
in circulation and at the site of inflammation (Kasperska-
Zajac et al., 2004). In this study, we showed that plasma
levels of 5-HT were increased in patients with AD, which
agrees with a previous report (Ring and O’Connor, 1979). In
addition, the levels of plasma 5-HT correlated with clinical
severity. It was also reported that platelets in some patients
with AD exhibited increased release of 5-HT after stimulation
(Ring and Dorsch, 1985). The plasma levels of 5-HT in
patients with AD are comparable to those seen in asthma
patients during attack, in which 5-HT uptake-enhancing drug
suppresses asthmatic symptom (Lechin et al., 1996, 2004). In
addition, scratching because of severe itch often results
in excoriation and subsequent platelet aggregation at the
lesion of AD. Engagement of FceRI on platelets by environ-
mental allergens may also take place in these lesions. 5-HT is
also known to be a pruritogenic factor and its release from
activated platelets induces further scratching and hemor-
rhage. The aggregation and activation of platelets at the sites
of excoriation suggests that the concentration of 5-HT at the
lesion is much higher than in the circulation. Our results
demonstrating that 5-HT activates monocytes and inhibits
apoptosis provide new insight into the pathologic mechan-
isms explaining the exacerbation and establishment of
chronicity of AD, although clinical relevance of such activity
needs further determination. The use of appropriate 5-HTR
antagonists may lead to new treatments against such allergic
diseases.
MATERIALS AND METHODS
Reagents
5-HT, methiothepin maleate (5-HTR1/6/7 antagonist) and a-methyl-
5-hyrdoxytryptamine (5-HTR2 agonist) were purchased from the
Sigma Chemical Co. (St Louis, MO). MDL-72222 (5-HTR3 antago-
nist), 5-carboxamidotryptamine maleate (5-HTR1/6/7 agonist), and a-
methyl-5-hydroxytryptamine hydrochloride (5-HTR3 agonist) were
obtained from Tocris Cookson Inc. (Bristol, UK). MCI-9042 (5-HTR2A
antagonist) was kindly provided by Mitsubishi Pharma Corporation
(Tokyo, Japan). Rabbit anti-human Bcl-2, Bcl-xL, Mcl-1 antibody and
FITC-conjugated antibody to active caspase-3 were obtained from
BD PharMingen (San Diego, CA). Phycoerythrin-conjugated anti-
CD40, CD80, CD86, and HLA-DR were also obtained from BD
PharMingen. Anti-CD95/Fas mAb CH11 (mIgM) were obtained from
Immunotech (Marseilles, France). All other reagents were obtained
from Sigma Chemical Co., unless otherwise stated.
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Cell preparation and cultures
Whole blood was collected from informed, healthy, nonatopic
volunteers and adult patients with chronic AD in accordance with
the guidelines and approval of the institutional ethics committee.
Participants gave their written informed consent and the study was
conducted according to the Declaration of Helsinki Principles.
Eleven adult chronic extrinsic AD patients (six males and five
females, history of AD: median 24 years, range 12–35 years, age:
median 30 years, range 16–35) were diagnosed according to the
criteria of Hanifin and Rajka (1980). The clinical severity of AD was
estimated by using the SCORAD index range (A European task force
on atopic dermatitis, 1993). Patients with moderate psoriasis (n¼ 10,
age: median 33 years old, range 20–48) without any history of atopic
diseases including AD, asthma, or allergic rhinitis also participated
in this study. Monocytes were isolated using Nycoprep (Nycomed,
Oslo, Norway) and a monocyte isolation kit with MACS system
(Miltenyi Biotec, Bergisch Gladbach, Germany). Purified monocytes
were resuspended at 2 106 cells/ml in culture medium containing
low-endotoxin RPMI 1640 (Biochrom KG, Berlin, Germany), 1%
antibiotic/antimycotic (Gibco BRL, Gaithersburg, ML), and 100mg/ml
polymyxin B in 12 75 mm polypropylene tubes (Falcon, BD
Labware, San Jose, CA) and were cultured at 371C under humidified
conditions. In some experiments, 10% fetal bovine serum (Gibco
BRL) was added to the culture medium. All plastic ware and culture
reagents were tested for the presence of endotoxin using the Limulus
amebocytes lysate E-toxate multiple test. Endotoxin levels were
always o10 pg/ml.
Flow cytometric analysis
Annexin V expression was determined to assess quantitatively the
percentage of cells undergoing apoptosis according to the manu-
facturer’s instructions (R&D Systems, Minneapolis, MN). This kit also
enabled us to detect late apoptosis by propidium iodide staining.
Subdiploid cell assessment was monitored in ethanol-permeabilized
cells using propidium iodide staining, as described previously (Katoh
et al., 2000). Surface phenotypes and intracellular expression of
Bcl-2 family proteins and activated caspase-3 were examined as
described previously (Katoh et al., 2000).
Proliferation assays
Mixed lymphocyte reactions were conducted in 96-well round-
bottom microtiter plates by adding irradiated (3000 rad) monocytes
to 1 105 allogeneic CD4þ T cells that were obtained by negative
selection with MACS (Miltenyi Biotec). After 4 days of incubation at
371C, cellular proliferation was assessed by uptake of [3H]-
thymidine (1.25 mCi/well added for 16 hours; Amersham Bioscience,
Little Chalfont, UK). Radioactive incorporation was measured by
standard liquid scintillation counting.
ELISA
The concentrations of TNF-a, IL-6, and IL-10 in the supernatants of
monocyte cultures were measured using commercially available
ELISA kits (R&D Systems). The concentration of 5-HT in the plasma
was measured using Serotonin EIA kit (LDN, Nordhorn, Germany).
RT-PCR
Total RNA from monocytes was prepared with TRIzol reagent
(Invitrogen, San Diego, CA). cDNA was synthesized using the
first-strand cDNA synthesis kit (Amersham Biosciences) according to
the manufacturer’s instructions. Semiquantitative PCR was per-
formed as described previously (Du¨rk et al., 2005), including
specific primer sequences for each gene. The PCR products were
electrophoresed on a 1.5% agarose gel and visualized with ethidium
bromide.
Measurement of nuclear translocation of NF-jB p65 and
ERK1/2 phosphorylation
Monocytes were cultured with or without 5-HT and 5-HTR agonists.
After 30 minutes, the relative amount of ERK1/2 phosphorylation was
measured using the cell-based ERK1/2 (Thr202/204) ELISA kit
(RayBio, Norcross, GA). Alternatively, nuclear extracts were
prepared according to the manufacturer’s instructions and free p65
was measured using the NF-kB p65 ActivELISA kit (IMGENEX, San
Diego, CA).
Statistical analysis
Statistical differences were determined by paired Student’s t-test.
Pearson’s correlation analyses were carried out to determine a
possible correlation between the 5-HT values and clinical markers,
such as total serum IgE levels, peripheral blood eosinophil counts,
and SCORAD index. P-values less than 0.05 were considered
statistically significant. Results are expressed as mean7SEM, unless
otherwise indicated.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was supported in part by a grant from the Japanese Ministry of
Education, Science, Sports, and Culture.
REFERENCES
Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P (2003) The G protein-
coupled 5-HT1A receptor causes suppression of caspase-3 through
MAPK and protein kinase C alpha. Biochim Biophys Acta 1640:85–96
A European task force on atopic dermatitis (1993) Severity of scoring of atopic
dermatitis: the SCORAD index. Dermatology 186:23–31
Ameisen JC, Meade R, Askenase PW (1998) A new interpretation of
involvement of serotonin in delayed-type hypersensitivity. J Immunol
142:3171–9
Badie B, Bartley B, Schartner J (2002) Differential expression of MHC class II
and B7 co-stimulatory molecules by microglia in rodent gliomas.
J Neuroimmunol 133:39–45
Barnes PJ (2001) Histamine and serotonin. Pulm Pharmacol Ther 14:
329–39
Benedict CR, Mathew B, Rex KA, Cartwright J, Sordahl LA (1986) Correlation
of plasma serotonin changes with platelet aggregation in an in vivo dog
model of spontaneous occlusive coronary thrombus formation. Circ Res
58:58–67
Bracci-Laudiero L, Aloe L, Caroleo MC, Buanne P, Costa N, Starace G et al.
(2005) Endogenous NGF regulates CGRP expression in human mono-
cytes and affects HLA-DR, B7 expression and IL-10 production. Blood
106:3507–14
Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM
(1995) Granulocyte macrophage colony-stimulating factor contributes to
enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest
95:211–8
Cazzola I, Matera MG (2000) 5-HT modifiers as a potential treatment of
asthma. Trends Pharmacol Sci 21:13–6
1954 Journal of Investigative Dermatology (2007), Volume 127
F Soga et al.
Serotonin Activates Human Monocytes
Chomarat P, Dantin C, Bennett L, Banchereau J, Palucka KA (2003) TNF
skews monocyte differentiation from macrophages to dendritic cells.
J Immunol 171:2262–9
Cloez-Tayarani I, Pete-Bertron AF, Venters HD, Cavaillon JM (2003)
Differential effect of serotonin on cytokine production in lipopolysac-
charide stimulated human peripheral blood monouclear cells. Int
Immunol 15:233–40
Du¨rk T, Panther E, Mu¨ller T, Sorichter S, Ferrari D, Pizzirani C et al. (2005)
5-hydroxytryptamine modulates cytokine and chemokine production in
LPS-primed human monocytes via stimulation of different 5-HTR
subtypes. Int Immunol 17:599–606
Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC
(1998) Increased platelet reactivity and circulating monocyte-platelet
aggregates in patients with stable coronary artery disease. J Am Coll
Cardiol 31:352–8
Green DR (1998) Apoptotic pathways: the roads to ruin. Cell 94:695–8
Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta
Dermatol Venereol 9:44–7
Hasegawa S, Pawankar R, Suzuki K, Nakahata T, Furukawa S, Okumura K
et al. (1999) Functional expression of the high affinity receptor for IgE
(FceRI) in human platelets and its’ intracellular expression in human
megakaryocytes. Blood 93:2543–51
Idzko M, Panther E, Stratz C, Muller T, Bayer H, Zissel G et al. (2004) The
serotoninergic receptors of human dendritic cells: identification and
coupling to cytokine release. J Immunol 172:6011–9
Iken K, Chheng S, Fargin A, Gouleit AC, Kouassi E (1995) Serotonin
upregulates mitogen-stimulated B lymphocytes proliferation through
5-HT1A receptors. Cell Immunol 163:1–9
Kasperska-Zajac A, Nowakowski M, Rogala B (2004) Enhanced platelet
activation in patients with atopic eczema/dermatitis syndrome. Inflam-
mation 28:299–302
Katoh N, Kraft S, Weßendorf JHM, Bieber T (2000) The high-affinity IgE
receptor (FceRI) blocks apoptosis in normal human monocytes. J Clin
Invest 105:183–90
Katoh N, Soga F, Nara T, Masuda K, Kishimoto S (2005) Histamine induces
the generation of monocyte-derived dendritic cells which express CD14
but not CD1a. J Invest Dermatol 125:753–60
Katoh N, Soga F, Nara T, Tamagawa-Mineoka R, Nin M, Kotani H et al.
(2006) Effect of serotonin on the differentiation of human monocytes into
dendritic cells. Clin Exp Immunol 146:354–61
Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A et al. (1995)
Stimulation of CD40 with purified soluble gp39 induces proinflamma-
tory responses in human monocytes. J Immunol 155:4917–25
Lagasse E, Weissman IL (1997) Enforced expression of Bcl-2 in monocytes
rescues macrophages and partially reverses osteoporosis in op/op mice.
Cell 89:1021–31
Laberge S, Cruinkshank WW, Bewer DJ, Center DM (1996) Secretion of IL-16
(lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T
cells in vitro. J Immunol 156:310–5
Lechin F, van der Dijs B, Orozco B, Lechin M, Lechin AE (1996) Increased
levels of free serotonin in plasma of symptomatic asthmatic patients. Ann
Allergy Asthma Immunol 77:245–53
Lechin F, van der Dijs B, Lechin AE (2004) Treatment of bronchial asthma
with tianeptine. Methods Find Exp Clin Pharmacol 26:697–701
Leung DYM, Bieber T (2003) Atopic dermatitis. Lancet 361:151–60
Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA (2004) New
insight into atopic dermatitis. J Clin Invest 113:651–7
Leung DYM, Rhodes AR, Geha RS, Schneider L, Ring J (1992) Atopic
dermatitis. In: Dermatology in General Medicine. (Fitzpatrick TB, Eisen
AZ, Wolff K, Freeberg IM, Austen KF. eds). New York: McGraw-Hill Inc,
1543–64
Lundeberg L, Liang Y, Sundstrom E, Nordlind K, Verhofstad A, Liden S et al.
(1999) Serotonin in human allergic contact dermatitis. An immunohis-
tochemical and high-performance liquid chromatographic study. Arch
Dermatol Res 291:269–74
Mangan DF, Mehgenhagen SE, Wahl SM (1993) Apoptosis in human
monocytes: possible role in chronic inflammatory diseases. J Periodontol
64:461–6
Mangan DF, Welch GR, Wahl SM (1991) Lipopolysaccharide, tumor necrosis
factor-a, and IL-1b prevent programmed cell death (apoptosis) in human
peripheral blood monocytes. J Immunol 146:1541–6
Mangan DF, Wahl SM (1991) Differential regulation of human monocytes
programmed cell death (apoptosis) by chemotactic factors and pro-
inflammatory cytokines. J Immunol 147:3408–12
Manna SK, Aggarwal BB (1999) Lipopolysaccharide inhibits TNF-induced
apoptosis: role of nuclear factor-kB activation and reactive oxygen
intermediates. J Immunol 162:1510–8
Matsuda H, Ushio H, Geba GP, Askenase PW (1997) Human platelets can
initiate T cell-dependent contact sensitivity through local serotonin
release mediated by IgE antibodies. J Immunol 158:2891–7
Novak N, Bieber T, Katoh N (2001) Engagement of FceRI on human
monocytes induces the production of IL-10 and prevents their
differentiation in dendritic cells. J Immunol 167:797–804
Page CP (1989) Platelets as inflammatory cells. Immunopharmacology
17:51–9
Polla BS, Ezekowitz RA, Leung DYM (1992) Monocytes from patients with
atopic dermatitis are primed for superoxide production. J Allergy Clin
Immunol 89:545–51
Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR (1992)
Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood
79:1201–5
Ring J, O’Connor R (1979) In vitro histamine and serotonin release studies in
atopic dermatitis. Int Archs Allergy Appl Immun 58:322–30
Ring J, Dorsch W (1985) Altered releasability of vasoactive mediator secreting
cells in atopic eczema. Acta Derm Venereol 114:9–23
Scheuere B, Ernst M, Iris D-L, Fleischer J, Grage-Griebenow E, Brandt E et al.
(2000) The CXC-chemokine platelet factor 4 promotes monocyte
survival and induces monocyte differentiation into macrophages. Blood
95:1158–66
Soga F, Katoh N, Kishimoto S (2007) Histamine prevents apoptosis in human
monocytes. Clin Exp Allergy 37:323–30
Tenda Y, Yamashita M, Kimura MY, Hasegawa A, Shimizu C, Kitajima M
et al. (2006) Hyperresponsive TH2 cells with enhanced nuclear
factor-kappa B activation induce atopic dermatitis-like skin lesions in
Nishiki-nezumi Cinnamon/Nagoya mice. J Allergy Clin Immunol
118:725–33
Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2
family and cell death. Blood 88:386–401
Yi-qun Z, Lorre K, de Boer M, Ceuppens JL (1997) B7-blocking agents, alone
or in combination with cyclosporin A, induce antigen-specific anergy of
human memory T cells. J Immunol 158:4734–40
Young MR, Kut JL, Coogan MP, Wright MA, Young ME, Matthew J (1993)
Stimulation of splenic T-lympchocytes function by endogeneous and
low-dose exogenous serotonin. Immunology 80:395–400
www.jidonline.org 1955
F Soga et al.
Serotonin Activates Human Monocytes
